Sofie Denies

Title: Sofie Denies: Innovator in Anti-TIGIT Antibodies

Introduction

Sofie Denies is a prominent inventor based in Gosselies, Belgium. She has made significant contributions to the field of biotechnology, particularly in the development of anti-TIGIT antibodies. With a total of 2 patents to her name, her work is paving the way for advancements in cancer immunotherapy.

Latest Patents

Sofie Denies holds two notable patents related to anti-TIGIT antibodies. These patents provide innovative solutions by offering antibodies and antigen binding fragments that inhibit TIGIT-mediated signaling. The patents also include combinations comprising these antibodies or antigen binding fragments and methods for their use, showcasing her commitment to advancing therapeutic options in oncology.

Career Highlights

Throughout her career, Sofie has worked with esteemed companies such as Iteos Therapeutics and Iteos Belgium. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Sofie has had the opportunity to work alongside notable colleagues, including Anthony B Cooper and Christophe Queva. These collaborations have further enriched her research and development efforts in the biotechnology sector.

Conclusion

Sofie Denies is a trailblazer in the field of anti-TIGIT antibodies, with her patents and collaborations reflecting her dedication to innovation in cancer treatment. Her work continues to inspire advancements in biotechnology and therapeutic development.